India's top drugmaker Sun Pharma beats profit view on specialty drugs demand

India's top drugmaker by revenue Sun Pharmaceutical Industries beat quarterly profit estimates on Friday helped by demand for company's high-margin specialty drugs used to treat complex conditions.

The Mumbai-based firm's consolidated net profit stood at 27.14 billion rupees ($283 million) for the quarter ended March 31, from 21.50 billion rupees last year.

That was above analysts' average estimate of 27.12 billion rupees, according to data compiled by LSEG.

($1 = 95.9125 Indian rupees)

(Reporting by Rishika Sadam and Kashish Tandon)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published May 22, 2026 at 5:20 AM.